Biomarin Pharmaceutical Inc (BMRN)

BMRN (NASDAQ:Drugs) EQUITY
$88.81
pos +0.86
+0.98%
Today's Range: 87.50 - 89.85 | BMRN Avg Daily Volume: 1,573,200
Last Update: 05/25/16 - 3:59 PM EDT
Volume: 1,062,649
YTD Performance: -16.07%
Open: $88.78
Previous Close: $87.95
52 Week Range: $62.12 - $151.75
Oustanding Shares: 162,322,439
Market Cap: 13,880,191,759
6-Month Chart
TheStreet Ratings Grade for BMRN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 11 10
Moderate Buy 2 2 2 1
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.40 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -73.09
Price Earnings Comparisons:
BMRN Sector Avg. S&P 500
-73.09 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
15.18% -30.85% 36.56%
GROWTH 12 Mo 3 Yr CAGR
Revenue 18.50 0.80 0.21
Net Income 0.00 0.50 0.00
EPS 0.00 0.10 0.00
Earnings for BMRN:
EBITDA -0.27B
Revenue 0.89B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $-0.50 $-0.56 $-2.19 $-1.38
Number of Analysts 12 11 12 12
High Estimate $-0.44 $-0.47 $-1.82 $0.04
Low Estimate $-0.63 $-0.66 $-2.65 $-1.98
Prior Year $-0.22 $-0.60 $-1.58 $-2.19
Growth Rate (Year over Year) -127.65% 6.06% -38.45% 36.99%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Bret Jensen Reporting for Duty Real Money Pro($)

Good morning -- Bret Jensen here! As always, it's good to be standing in for Doug Kass.
The big downtrend line was broken decisively.
BMRN could re-base in the weeks and months ahead as downside looks limited. 
Also, Pfizer-Allergan deal clears another hurdle.
Once again, buyers are going for the gusto.
Drug companies are just too big a target to ignore.
Which means interest rate hikes are being built into prices.
The bulls can show them around the place.

Columnist Conversations

Bunge (NYSE:BG) declared a $0.42/share quarterly dividend, a 10.5% increase from its prior dividend rate of $0...
Today's strength in ES (Emini S&P 500) ripped above the May 10 high at 2079.75. This invalidates the March...
Record call volume in Craft Brew Alliance after four day rally. Shares up nearly 5% near $9.19 after lifting 9...
Market having another strong day. Energy shares strong as oil tries to broach $50 a barrel. Seeing some con...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.